Pieris Pharmaceuticals, Inc. (PIRS)

5.62
NASDAQ
Prev Close 5.44
Day Low/High 5.45 / 6.15
52 Wk Low/High 1.70 / 6.06
Exchange NASDAQ
Shares Outstanding 66.71B
Market Cap 362.91M
P/E Ratio N/A
Div & Yield N.A. (N.A)
Opening the Biotech Mailbag to Find Big News About a Trio of Stocks

Opening the Biotech Mailbag to Find Big News About a Trio of Stocks

There's a merger involving one company, a collaborative agreement for another and hints of a positive regulatory development for a third.

3 Names Making the Case That Investing in Small Biotech Is Never Dull

3 Names Making the Case That Investing in Small Biotech Is Never Dull

Karyopharm Therapeutics and Pieris Pharmaceuticals are climbing this week on positive news, while Supernus Pharmaceuticals takes a hit.

2 Small Biotechs I Like in the Second Half

2 Small Biotechs I Like in the Second Half

Adamis Pharmaceuticals and Pieris Pharmaceuticals are names to watch.

3 Small Biotech Stocks Insiders Are Buying

3 Small Biotech Stocks Insiders Are Buying

Verastem Inc., Pieris Pharmaceuticals and Intra-Cellular Therapies all have promising products.

These 3 Small Biotechs Have a Healthy Shot

These 3 Small Biotechs Have a Healthy Shot

Several firms hiked price targets on Portola into the $70s this week.

Give These 3 Small Biotechs a Shot

Give These 3 Small Biotechs a Shot

Several firms hiked price targets on Portola into the $70s this week.